Skip to main content
. Author manuscript; available in PMC: 2011 Apr 1.
Published in final edited form as: Pharmacogenet Genomics. 2009 Dec;19(12):923–934. doi: 10.1097/FPC.0b013e3283330767

Figure 1.

Figure 1

Identification of UGT2A2 mRNA in human fetal nasal mucosa. PCR (45 cycles) was performed using reverse transcribed mRNA from human fetal nasal mucosa, lung, and liver (2 fetuses each) and from human adult liver (pooled from 47 donors). Primers were designed to be specific for human UGT2A2 and β-actin. PCR products were run on a 2% agarose gel and visualized by ethidium bromide staining. Expected product sizes were 144 bp (UGT2A2) and 214 bp (β-actin).